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Background: Systematic procedures addressing the limitations of eligibility determination are needed to improve
the quality of participant recruitment and enrollment in randomized clinical trials. This paper describes an eligibility
determination process developed by and in use at a chiropractic research center engaged in community
recruitment for clinical trials studying spinal pain conditions.
Methods: A team of investigators developed a case review process for application across clinical trials involving
chiropractic care. Study personnel representing key study roles including research clinicians, study coordinators, a
project manager, and at least one investigator convene in person to determine eligibility for participants following
baseline study visit examinations. The research clinician who performed the eligibility examination presents the case
and a moderator leads the case review panel through a structured discussion including diagnosis, eligibility criteria,
definition review, and clinical precautions. Panel members provide clinical recommendations and determine final
eligibility using a structured and moderated voting process.
Results: Through the case review process for three externally funded clinical trials for participants with neck and
low back pain, we presented 697 cases, rendering 472 participants eligible for enrollment and excluding 225
individuals. The most common reasons for case review exclusions across the three trials included neck or back pain
not meeting diagnostic classifications, safety concerns related to treatment or testing, referral for further evaluation
or treatment, and compliance concerns.
Conclusions: The case review process uses the expertise of study coordinators, research clinicians, project
managers, and investigators to render eligibility decisions consistent with study aims for the duration of the trial.
This formal eligibility determination process includes steps designed to mitigate the potential for participant
misclassification from clinician advocacy or misunderstanding of eligibility criteria, and helps ensure that participants
can safely take part in study procedures.
Trial registration: The three trials discussed in this article were registered in ClinicalTrials.gov with the ID numbers
of NCT00830596 (27 January 2009), NCT01312233 (04 March 2011), and NCT01765751 (30 May 2012).
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Eligibility criteria for clinical trials are designed to en-
sure the safety of research participants [1] and reflect
the scientific objectives of a study [2]. Automated eligi-
bility determination systems help strengthen the enroll-
ment process by standardizing decisions so that study
personnel do not influence the selection process [3,4].
However, in most clinical trials, investigators or their des-
ignees determine whether individual participants meet
selection criteria, a process vulnerable to selection bias be-
cause of subjective interpretations [5] and the personal
views of study personnel [6]. Thus, a challenge for clinical
trial researchers is to render eligibility determination with
procedures that facilitate consistent decision-making and
avoid enrollment error, thereby reducing the opportunity
for participant risk [1,7,8]. Determinations that lack a con-
sistent and transparent process may lead to an unrepre-
sentative sample [9] and influence the generalizability of
study results [10,11].
Although inclusion and exclusion criteria are reported
routinely in scientific publications [12], the specific pro-
cesses by which participant eligibility is determined and
selection bias mitigated are often unclear. A 2010 system-
atic review studying interventions for improving adher-
ence to eligibility criteria in randomized controlled trials
did not find any primary publications describing such pro-
cedures [5]. Thus, there is a need to report eligibility de-
termination procedures specifically designed to address
potential limitations and to reduce the need for clinical
trial managers to continually re-invent this process, which
is necessary when established methods are not yet docu-
mented or disseminated broadly [13].
This article describes a multidisciplinary eligibility de-
termination process developed and in use at a research
center engaged in community-based recruitment for clin-
ical trials of chiropractic care for non-surgical spinal pain.
Our research teams developed this process to determine
eligibility requiring clinical decision-making for three
federally-funded randomized clinical trials in the United
States: Trial 1 was a study of spinal manipulation with
physiological and kinetic measurements for 221 adults
aged 21 to 65 years with sub-acute or chronic low back
pain [14]; Trial 2 was a study of collaborative care involv-
ing chiropractic and medical care for 131 participants with
low back pain in adults aged over 64 years [15]; and Trial
3 was a study utilizing spinal traction mobilization for 48
adults aged 18 to 70 years with neck pain.
Methods
Ethics approval
Trials 1 and 3 were overseen by and received ethical ap-
proval from the Palmer College of Chiropractic Institu-
tional Review Board (assurance numbers 2007M093 and
2012G151). Trial 2 was overseen and approved by boththe Palmer College of Chiropractic and Genesis Health
Systems Institutional Review Boards (assurance numbers
2011G138, 11-005). The institutional review boards ap-
proved the study protocols that included the case review
process discussed in this manuscript. All study partici-
pants provided written informed consent.
Clinical trials overview
We developed our case review process for eligibility de-
termination during three separate clinical trials con-
ducted with overlapping enrollment periods over a 5
year timespan. Trial 1 [14] was conducted to determine
pre- to post-treatment changes in postural sway follow-
ing spinal manipulation. Participants with acute, sub-
acute, or chronic low back pain received 13 treatments
over 6 weeks of either i) high velocity, low amplitude
spinal manipulation; ii) low velocity, variable amplitude
spinal manipulation; or iii) sham treatment. Sensori-
motor measures included postural sway, repositioning
accuracy, and response to a sudden load. Table 1 in-
cludes the specific eligibility criteria for Trial 1.
Trial 2 [15] was a 12-week study conducted to evalu-
ate the feasibility of a collaborative care model for
chronic low back pain treatment in adults 65 years or
older. Participants were allocated to one of three treat-
ment groups: i) conventional care by a family medicine
physician; ii) medical and chiropractic care separately
but concurrently provided by a family medicine phys-
ician and a doctor of chiropractic; and iii) collaborative
care by both a family medicine physician and a doctor
of chiropractic. Table 2 lists the eligibility criteria for
Trial 2 as listed in the study protocol.
Trial 3 was conducted to study a manual cervical dis-
traction procedure for adults with radiating neck pain.
Trial 3 represents the most recent iteration of the case re-
view process and was conducted to i) measure the ability
of chiropractic research clinicians to deliver a cervical
traction mobilization procedure within specified force
ranges and ii) provide preliminary outcomes data for a fu-
ture full-scale clinical trial. There were five study visits
and all included manual cervical distraction delivered
within three treatment group-specific force ranges. Bio-
mechanical procedures included repeated neck range of
motion testing in multiple positions and performing re-
peated isometric muscular contractions in the cervical re-
gion. Table 3 presents eligibility criteria as listed in the
study protocol and assessed during case review for Trial 3.
Automated eligibility screening process
Eligibility determination is a multi-staged process that
begins when an interested community-based volunteer
contacts our research center via phone, direct mail
post card, e-mail, or in person to initiate the screening
process [16]. Research personnel provide the volunteer
Table 1 Eligibility criteria determined during case review for Trial 1
Inclusion criteria Rationale
Acute, sub-acute, or chronic low back pain matching
Quebec Task Force classifications 1, 2, 3, or 7
Low back pain, uncomplicated by known nerve root compression, neurological
signs, or prior surgery
Exclusion criteria Rationale
Bleeding disorders Potential intolerance to biomechanical testing or treatment protocols
Vascular claudication Potential intolerance to biomechanical testing protocols
Bone and joint abnormality Potential intolerance to biomechanical testing or treatment protocols
Inflammatory or destructive tissue changes to the spine Potential intolerance to biomechanical testing or treatment protocols
Osteoporosis Potential intolerance to biomechanical testing or treatment protocols
General poor health Overall condition is too poor to tolerate treatment and biomechanical testing procedures
Neuromuscular diseases Condition may interfere with data collection/interpretation
Peripheral neuropathies Condition may interfere with data collection/interpretation
Prior spinal surgery Condition may interfere with data collection/interpretation
Suspicion of drug or alcohol abuse Condition may interfere with data collection, ability to comply with study protocol, and
requires referral
Contraindication to spinal manipulation Safety concern for treatment protocols
Low back pain matching Quebec Task Force
classifications 4 to 6 and 8 to 11
Condition of sufficiently complicated nature to cause intolerance to biomechanical
testing procedures or data collection
Cauda equina syndrome Requires emergency surgical evaluation
Further diagnostic procedures other than
dipstick urinalysis or X-rays
Advanced diagnostic tests outside study scope
Compliance concerns May compromise ability to adhere to study protocol
Vining et al. Trials 2014, 15:406 Page 3 of 12
http://www.trialsjournal.com/content/15/1/406with basic information about the trial and conducts a
computer-assisted telephone interview (phone screen) to
assess preliminary eligibility. A phone screen-eligible par-
ticipant is scheduled for an in-person baseline visit that in-
cludes an informed consent process conducted by a study
coordinator. A consented participant then completes re-
search questionnaires and an interview with the study co-
ordinator to review select eligibility criteria. The study
coordinator enters objective eligibility data that do not
require clinical decision making (e.g., pain rating, body
mass index, depression index) into a web-based partici-
pant tracking system programmed to generate automated
decisions for specific eligibility criteria [17]. Participants
who do not meet eligibility criteria at this point are ex-
cluded from the study and thanked for their interest and
participation.
If eligible after the interview with the study coordin-
ator, the participant receives a clinical evaluation from a
research clinician who is a licensed doctor of chiroprac-
tic. The clinical evaluation includes a detailed health his-
tory review and focused examination of the spinal region
under investigation. Additional clinical evaluation may
occur when the health history, symptoms or examin-
ation findings merit further assessment to obtain infor-
mation necessary to render clinically-related eligibility
decisions or to determine whether referral to another
provider is warranted. Clinicians may also use standard
radiography when clinically appropriate [18]. Followingthe clinical evaluation, the research clinician completes an
eligibility questionnaire on the web-based tracking system,
entering only objective inclusion or exclusion criteria that
require clinical evaluation, but which are not related to
the diagnosis under study such as surgical history or the
presence of a fracture. Participants may be excluded at
this point by the research clinician. Participants who re-
main eligible following the baseline clinical evaluation
move forward for formal eligibility determination at the
case review meeting.
Case review eligibility determination
The case review panel consists of 6 to 12 study personnel
representing key roles and includes 2 to 4 research clini-
cians, 2 to 4 study coordinators, 1 clinical project man-
ager, and the senior research clinician who leads the panel
and is a trial investigator. Other personnel or study inves-
tigators may also be included in the panel depending on
trial requirements. At least half of the study coordinators
and research clinicians participating on the panel are
graduate students enrolled in a master’s degree program
in clinical research. All graduate students are degreed
healthcare professionals (doctors of chiropractic); case re-
view serves as a foundational training experience in the
conduct of clinical trials for these students.
The case review panel typically meets twice per week
for 1.5 hours per session. A study coordinator prepares
paper and electronic records to assure their availability
Table 2 Eligibility criteria determined during case review for Trial 2
Inclusion criteria Rationale
Low back pain diagnosis consistent with Quebec
Task Force classifications 1 to 9
Low back pain classifications commonly treated by both doctors of chiropractic
and primary care physicians
Exclusion criteria Rationale
Low back pain diagnosis consistent with Quebec
Task Force classification of 10 or 11
Classification 10 (chronic pain syndrome) and Classification 11 (other low back pain
causes such as visceral disease, metastasis, and spondylitis) require treatment outside
the scope of the trial
Spinal surgery in past 3 months Potential to confound health outcomes
Fracture in any location in the body in 6 weeks Recent fracture may influence ability to measure pain-related health outcomes;
participant safety concern
Active carcinoma/metastatic disease or current
treatment for any form of cancer
Serious health condition requiring medical treatment during study period; participant
safety concern
Serious concomitant illness or co-morbidity preventing
delivery of care of any available treatments
Potential to confound health outcomes
Serious concomitant illness or co-morbidity requiring
coincident medical treatment
May interfere with study requirements or pose a significant scheduling burden
to participants during study period
Contraindication to chiropractic care in primary
treatment area
Safety precaution for treatment protocols
Aortic aneurysm (or suspicion of) >5 centimeters Safety precaution for treatment protocols; need for referral for further evaluation
or treatment
Need for advanced laboratory testing or diagnostic
imaging or referral to a healthcare provider
Safety precaution for treatment protocols; potential need for further evaluation
or treatment outside that provided by study protocol
Other clinical concerns for safety of available treatments Safety precaution for treatment protocols
Activities of daily living, mobility, or sensory impairment Severe impairments may pose a safety concern or impair delivery of available
treatments in outpatient study facilities
Cognitive or memory impairment May prohibit informed consent or compromise safety due to potentially reduced
comprehension or compliance with study procedures
Suspicion of alcohol or drug abuse May interfere with data collection, ability to comply with study protocol, and
requires referral/management
Compliance concerns May compromise ability to adhere to study protocol
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work file servers hold documents containing personal
health information. A web-based manual of operating pro-
cedures is also available to reference study protocols, eligi-
bility criteria, and operational definitions for individual
studies. The goals for the case review meeting are to: i) en-
sure complete and consistent case presentation; ii) en-
courage contributions by all panel members; iii) establish
the clinical diagnosis [19]; and iv) reach consistent and
scientifically-valid eligibility decisions.
Case review is initiated by a study coordinator who also
serves as moderator and leads the panel through the eligi-
bility determination process using a stepwise flowchart.
Figure 1 depicts the case review flowchart for Trial 3.
Flowcharts depicting the case review process for Trial 1
and Trial 2 are illustrated in Figures 2 and 3, respectively.
The moderator manages the case review discussion, en-
sures that each step of the process is addressed before
subsequent discussion topics are introduced, and tallies
consensus votes. Thus, the moderator allows the re-
search clinician to focus on the presentation of the
case, panel members to listen to the presentation andformulate discussion questions, and the project man-
ager and senior clinician to oversee that the case review
process addresses the eligibility criteria as outlined in
the study protocol.
The moderator first asks the study coordinator who
completed the informed consent process to introduce
the participant and disclose information that could affect
eligibility such as factors that could influence the ability
to comply with study procedures (e.g., family responsi-
bilities, work schedule, transportation issues). Next, the
moderator directs the research clinician to present im-
aging findings and health records obtained elsewhere,
when available. Following the health records review, the
research clinician provides a formal case presentation in-
cluding a detailed health history, focused history of the
chief complaint, review of systems, and findings from
the clinical evaluation.
Following the case presentation, the moderator desig-
nates each panel member an opportunity to ask ques-
tions. The research clinician answers panel members’
questions as they are posed. When all panel questions are
addressed, the moderator directs the research clinician to
Table 3 Eligibility criteria assessed during case review for Trial 3
Inclusion criteria Rationale
Neck or neck-related upper limb pain consistent with
Quebec Task Force classifications 2 to 4
Neck pain radiating to proximal or distal extremity with or without
neurological signs is commonly treated by doctors of chiropractic
using study procedures
Naïve to flexion-distraction manual therapy procedures to cervical area Requires participant unfamiliarity with study interventions
Exclusion criteria Rationale
Neck pain consistent with Quebec Task Force classifications 1, 5 to 11 Classifications represent diagnoses that may require individualized
treatment not available in trial; condition(s) may limit interpretation
of study measurements
Bone/joint pathologies representing a contraindication to
study procedures, including but not limited to:
1) Inflammatory arthritis involving the cervical spine: i.e.,
rheumatoid arthritis, systemic lupus erythematosus, etc.
Study prescribed treatments are not intended for these conditions; may
require referral and interfere with data collection and interpretation
2) Any condition representing neurological (spinal) instability in
cervico-thoracic spine
Condition requires referral for evaluation or care outside study scope
3) Tumors, within or adjacent to the cervico-thoracic spinal canal Condition requires evaluation or care outside study scope
4) Arnold Chiari malformation May represent condition requiring referral for evaluation or care and
limit interpretation of study measurements
5) Disorders known to exhibit spinal joint hypermobility, such as:
Marfan syndrome, Ehlers-Danlos syndrome, osteogenesis imperfecta
May represent condition requiring referral; may interfere with data
collection and interpretation
6) Cervico-thoracic disc herniation or prolapse demonstrating
advancing neurologic deficits
Condition requires referral for evaluation or care outside study scope
7) Sequestered intervertebral disc fragment or loose bodies within
the spinal canal, lateral recess, or intervertebral foramen
Safety precaution for available treatment protocols and may
require referral
8) Any condition not listed above representing a contraindication
to or a safety risk for study procedures
Safety precaution for treatment or biomechanical testing protocols
and may require referral
Any single or multisegmental fusion (surgical or congenital) of
the first through the seventh cervical vertebrae
Intervention hypothesizes that joint distraction and intervertebral
disc pressure change are principal therapeutic mechanisms
Safety precaution (e.g., inability to safely ambulate within clinic, dizziness
when arising or lying on treatment table, anxiety from study procedures)
Safety precaution and may interfere with participant’s ability to
comply with study protocol
Unable to tolerate study procedures Safety precaution for treatment or biomechanical testing procedures
Simultaneous management for condition compromising ability to
deliver study treatment or assess health status
Safety precaution for treatment protocols and may present an undue
scheduling burden
Suspicion of alcohol or drug abuse May interfere with data collection, ability to comply with study
protocol, and requires referral
Cognitive or memory impairment May prohibit informed consent or compromise safety due to potentially
reduced comprehension or compliance with study procedures
Referral for evaluation/management of other condition(s) or
further testing required for neck pain diagnosis
Safety precaution and extensive or advanced diagnostic testing
outside study scope
Compliance concerns* May compromise ability to adhere to study protocol
*Compliance definition: Participants identified with compliance concerns (e.g., travel or transportation issues, conflicts with work or other routinely schedule
activities, concerns with family or caregiving responsibilities, repeated scheduling issues during baseline evaluations, reluctance to receive treatment from study
doctors only) will be discussed at Case Review and considered for exclusion on a case-by-case basis.
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ational definitions, which are displayed electronically for
the panel. The moderator then verbally polls each panel
member individually regarding whether any particular ex-
clusion criterion is met or requires discussion or clarifica-
tion and tallies the poll results. If no exclusion concern
exists, the moderator addresses the next item on the case
review flowchart (e.g., diagnosis determination).
When an exclusion reason is posed by a panel member,
the moderator reviews the corresponding study-specificeligibility definition. The moderator again verbally polls
each panel member individually to determine the degree
of consensus. Members provide verbal answers on their
agreement with the exclusion criterion, along with justifi-
cation for their opinion. When an eligibility decision can
only be rendered after the diagnosis is determined, exclu-
sion discussion is pended until after diagnosis confirm-
ation by the panel. Each proposed exclusion decision
occurs separately by a voting process. Consensus occurs
when at least 80% of the panel members present agree
Figure 1 Case review flowchart for the manual cervical
distraction trial (Trial 3). Yellow boxes, case review moderator
process; Light grey boxes, study coordinator process; Dark grey
boxes, research clinician process; Green boxes, senior clinician
process; Purple boxes, case review panel process.
Figure 2 Case review flowchart for the spinal manipulation and
sensorimotor function trial (Trial 1). Light grey boxes, study
coordinator process; Dark grey boxes, research clinician process;
Green boxes, senior clinician process; Purple boxes, case review
panel process.
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sus is not reached, the senior research clinician, or
other designated trial investigator, renders final eligi-
bility determination.
Once eligibility consensus is reached, the research clin-
ician completes the participant-specific case review formlocated on a secure, password-protected web module
programmed with study-specific exclusion criteria. The
eligibility decision, along with the reasons for exclusion,
comments regarding the case review process including
whether or not consensus was reached, and the names
of the research personnel who participated in the case
review discussion are documented. The research clin-
ician who performed the examination contacts partici-
pants excluded at case review to inform them of their
eligibility status, report their findings, and provide clinical
Figure 3 Case review flowchart for the collaborative care trial
(Trial 2). Light grey boxes, study coordinator process; Dark grey
boxes, research clinician process; Green boxes, senior clinician
process; Purple boxes, case review panel process.
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mendations for conditions such as abdominal aortic
aneurysm, peripheral arterial disease, severe hyperten-
sion (urgency/crisis), evaluation for other suspected or
unmanaged health conditions, and counselling for alcohol
or drug dependence may also occur at this time. Partici-
pants included at case review are scheduled for the next
study visit, which includes concealed allocation.
Results
Combined trial results
Our case review panel rendered eligibility determination
decisions for three separate clinical trials from January2009 through December 2013. The case review panel
considered a total of 697 cases, excluded 225 participants,
and allocated 400 participants across the three trials. Of
the 225 exclusions at case review, 156 participants were
excluded from Trial 1, 33 participants from Trial 2, and
36 participants from Trial 3. Table 4 outlines the eligibility
determination dispositions across the three clinical trials.
The number of participants excluded for each eligibility
criterion are presented by study in Table 5 (Trial 1),
Table 6 (Trial 2), and Table 7 (Trial 3).
Across the three trials, 72 participants who were deemed
eligible for random allocation at case review were not ran-
domized into a study, including 51 participants in Trial 1,
9 participants in Trial 2, and 12 participants in Trial 3. Of
these, 28 participants (Trial 1 = 16 participants, Trial 2 = 7
participants, and Trial 3 = 3 participants), decided not to
continue in their respective trial, usually citing time com-
mitment conflicts with work or family as their reasons for
non-participation. Another 20 participants in Trial 1 and 2
participants in Trial 3 did not return to the clinic after be-
ing eligible at case review, and thus were never randomly
allocated to treatment. Finally, 24 participants (Trial 1 = 15
participants, Trial 2 = 2 participants, and Trial 3 = 7 partici-
pants) were excluded from their respective trials after being
eligible at case review due to an exclusionary response at
the pre-allocation interview, with the majority of these ex-
clusions (n = 18) categorized as no longer meeting the
established pain rating threshold for the study.
The most common reasons for exclusion across the
three trials included neck or back pain not meeting the
stipulated Quebec Task Force for Spinal Disorders classifi-
cation [20]. Other common exclusions occurred for safety
concerns related to treatment or testing procedures, refer-
ral for the neck or back pain condition or other health
concern, participant-reported alcohol or drug use, and
concerns related to a participant’s ability to comply with
the study protocol. No participants were reported to the
principal investigators as inappropriately enrolled in the
respective trials. However, several participants withdrew
from each trial and may, in some cases, represent persons
who were judged incorrectly by the panel to be those who
would be compliant with study protocols. In total, 34 par-
ticipants withdrew or were lost to follow-up across the 3
trials: 22 participants from Trial 1; 9 participants in Trial
2; and 3 participants from Trial 3. We were unable to ob-
tain reasons for withdrawal for the majority of these en-
rolled participants due to loss of contact.
Trial 3 results
Figure 4 presents the eligibility decisions from Trial 3 as
an exemplar of our multi-staged process for eligibility de-
termination. Study personnel initiated 291 phone screens
that 9 participants opted not to complete and through
which 72 participants were excluded per the automated
Table 4 Eligibility determinations for three clinical trials
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these exclusions (n =48) being related to neck pain rat-
ings outside those established for this study (3 to 7 on a
0 to 10 numerical rating scale). We scheduled 210 baseline
1 evaluations in which 95 participants opted not to con-
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*Other exclusions included compliance concerns, referral needed, peripheral
neuropathy, neuromuscular disease, or participant unable to tolerate
study procedures.
^Safety risks related to treatment or testing procedures such as
inflammatory spondyloarthropathy.
#Quebec Task Force for Spinal Disorders classifications 4 to 6 and 8 to 11 were





*Evaluation or referral reasons such as recent medication changes with new
onset of side effects, cardiovascular symptoms (e.g., unstable angina, new
onset cardiac symptoms), progressive neurological signs/symptoms,
depression or other mental health concern, etc.
^Compliance concerns such as transportation issues, family or work
responsibilities, or reluctance for randomization to medical care group.
%Concurrent clinical management such as advanced renal disease or
cardiovascular disease.
#Quebec Task Force for Spinal Disorders classifications 10 to 11 were
exclusionary in this trial.through the automated process, again, with most exclu-
sions (n =14) related to self-reported neck pain rating. A
total of 96 participants were brought forward to the case
review meeting for eligibility determination, during which
36 were excluded from further participation. A total of 48
participants were allocated to treatment in Trial 3. Of the
remaining 12 who were not allocated, 5 participants chose
not to continue with the study and 7 rated their pain level
outside the established inclusion criteria for the trial.
Table 7 presents the reasons why participants were ex-
cluded from Trial 3 at case review. All exclusions were due
to a specific eligibility criterion. Twenty-five participants
were excluded for a single exclusion criterion while 11
were excluded for multiple criteria (varying from 2 to 4 ex-
clusions). Participants were most often excluded for neck
pain not matching the modified Quebec Task Force for
Spinal Pain classification ratings 2 to 4 [20,21] (n =13), an
inability to tolerate study procedures during the baseline
examination (n =9), referral needed for neck pain or other
health condition (n =8), self-reported high levels of alcohol
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Safety 3 4 7
















*Modified Quebec Task Force for Spinal Disorders classifications 1 and 5 to 11
were exclusionary for this trial.
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struments (n =7) [22-24], and the inability to safely receive
study treatments or perform biomechanical tests (n = 7).
We did not systematically collect the number of eligi-
bility determinations where case review panel consensus
was not reached until Trial 3. The study investigator
made 3 of 96 (3%) decisions under circumstances where
the case review panel did not achieve at least 80% con-
sensus on the eligibility determination. The investigator
excluded one participant on the suspicion of alcohol de-
pendence or abuse, one for referral to evaluate another
health condition, and one for the inability to safely toler-
ate the study treatment and biomechanical tests.
Resource considerations
Eligibility discussions during case review varied from 15 mi-
nutes to 1.5 hours (averaging 30 minutes) per participant,
meaning a substantial amount of combined personnel time
is dedicated to the process. Lengthy decisions tended to
occur early in the clinical trial, when participants wereexcluded for multiple reasons, or when new panel mem-
bers, typically graduate students in the clinical research
program, were present and more time was dedicated to
reviewing study aims, definitions, protocols, and dis-
cussing rationale for decisions. At our facility, each
panel member dedicated 7.5% of their working hours to
case review meetings (3 hours/week).
Discussion
The novel case review process presented here is a system-
atic method to mitigate selection bias in clinical trials of
spinal conditions for subjectively determined eligibility
criteria such as clinical diagnosis, tolerance of study
procedures, participant safety, need for referral, sub-
stance abuse, and compliance concerns. Our structured
case review process creates an environment for collab-
orative discussion, which includes vital contributions
from clinicians, coordinators, and investigators who fill
fundamentally different yet synergistic roles in the eligi-
bility determination process for participants enrolling
in a clinical trial. Each panel member is solicited to voice
their perspective so as to capitalize on their unique expert-
ise and experience to: i) facilitate clinical and scientific in-
terpretation of eligibility criteria; ii) ensure participant
safety regarding the ability to perform and receive trial
procedures; and iii) mitigate selection bias by providing an
environment to challenge, and therefore encourage, justifi-
able decision making, consistent with established eligibility
definitions.
Unfortunately, we cannot compare the effectiveness
or efficiency of our case review process with other
methods for eligibility determination as the biomedical
literature is silent regarding standard or systematic pro-
cedures designed to accurately enroll participants into
clinical trials, particularly where clinical decision mak-
ing is required [5]. This article represents a first step in
describing systematic methods that specifically incorp-
orate steps to mitigate selection bias where it is known
to occur.
Our case review process is designed with the aware-
ness that clinicians and other healthcare professionals
do not always make eligibility determinations consistent
with study aims or established inclusion and exclusion
criteria. For example, clinicians may avoid enrolling eli-
gible patients into a clinical trial because of the per-
ceived effect such participation could have on the
current doctor-patient relationship and to avoid feelings
of responsibility if treatments were found to be unequal
[25]. Clinicians also may prefer one trial therapy over
another [6,25-27] or avoid enrolling participants due to
the concerns that the patient might receive a placebo
[28]. Clinicians have reported reluctance to enroll study
participants due to the complexity of clinical trials [26],
the practical difficulty in following procedures, dislike
Figure 4 Eligibility decisions from the multi-staged determination
process for the manual cervical distraction trial (Trial 3).
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[25], and excessive time commitment [28]. Interviews
with hospital personnel involved in one clinical trial
found personal judgments about patients possibly ex-
plains why more than 50% of eligible patients did not
receive an explanation of a study they could have been
involved with [27].
Healthcare professionals may experience conflict be-
tween what they understand as their clinical responsi-
bility to the patient and the variables by which trial
eligibility decisions should be made. Clinicians may not
fully understand key components of clinical research
and may lack time, motivation, or opportunity to be-
come knowledgeable about study procedures. However,
skilled clinical assessment is usually essential for eligi-
bility determination. To address this issue, our process
includes clinicians and other study personnel to con-
firm interpretation of clinical information and to serveas a quality control mechanism. Our case review proce-
dures and the inclusion of at least one study investiga-
tor [29] in the eligibility determination process are
intended to prevent selection drift [30] and may be
beneficial during trials in which participant recruitment
lasts several years, occurs in multiple sites, or when im-
plementation occurs with changing staff.
Eligibility assessment for clinical trials involving non-
surgical spinal pain is challenging, in part because of
the difficulties in establishing a definitive diagnosis
[19,31]. Other limitations include incongruent termin-
ology among investigators, clinicians, and other study
personnel with divergent areas of expertise involved in
eligibility determination [32]. Without the use of con-
sistent terminology it is easy to conceive of eligibility
decisions that are inconsistent with criteria as envi-
sioned by investigators. One example of inconsistent
medical terminology is represented by the term lumbar
spinal stenosis. Lumbar spinal stenosis is an imaging
finding (a narrowed vertebral canal) whereas the clin-
ical diagnosis of lumbar stenosis syndrome, with sub-
types, is characterized by both imaging findings and
distinctive symptoms. However, a variety of terms are
used to describe the clinical condition [33,34]. Without
clear definitions of the clinical presentation, detailed
examination procedures, and the specific factors indi-
cating inclusion or exclusion, determining eligibility in
a consistent manner can be difficult.
Because eligibility criteria can be unclearly defined
[35] or interpreted inconsistently [27], we provide elec-
tronic access to study protocols and definitions during
case review meetings. Real-time access to study proto-
cols and definitions is designed to help prevent errant
decisions due to complex study designs or protocols,
and inadvertent misunderstanding [13]. We believe it is
especially helpful when conducting simultaneous trials.
We incorporate mandatory review of all eligibility cri-
teria into our case presentations. To further prevent def-
inition drift or systematic misunderstanding we include
at least one investigator in case review meetings. The in-
vestigator also serves in the role of clarifying definitions,
answering questions when they arise, and rendering final
determination when consensus is not reached.
While our research center has automated the eligibility
determination process for objective criteria, there remain
eligibility decisions requiring clinical expertise that are
more subjective in nature. The safety of participants
when a manual therapy is delivered per the allocation
scheme instead of tailored to an individual’s condition
[36], the ability to tolerate and safely undergo challen-
ging biomechanical tests without condition aggravation,
the need to refer for further evaluation or treatment of a
health condition, and the ability of a participant to
comply with the study protocol [37] are eligibility
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ing or the personal biases of study personnel. The
consensus-based case review process described here uses
expertise from across the research team and a stepwise
procedure to systematically render and support these
decisions.
This eligibility determination process is not without its
limitations. The diagnosis of spinal disorders is challen-
ging [31,38,39]; participants often present with multiple
overlapping conditions and a diagnosis is often based on
the clinical interpretation of a wide range of information.
We include multiple clinicians to aid this process. How-
ever, participants are not present during panel discus-
sions of their case to provide clarifying information
about their health history due to the challenges and
costs of scheduling this additional visit. When the case
review panel determines that additional information is
needed, the eligibility decision is pended and the partici-
pant is re-contacted by a research clinician. Additional
information is then presented to the panel at a future
case review meeting for final eligibility determination. In
addition, the act of verbally polling the opinions of panel
members, necessary to confirm if reasons for individual
eligibility decisions are consistent with study aims and
operational definitions, can potentially hinder the free
expression of thoughts and influence panel members.
This case review process is limited by personnel sched-
ules and the amount of time and resources study teams
allot to the process of eligibility determination. Our re-
search center and personnel dedicate more time to the
case review process than may be available elsewhere. We
estimate that this case review process may work suffi-
ciently with as few as three to four panel members. Fur-
ther, key components of the case review process are
transferrable to other research environments, including
those that train students and clinicians to conduct clinical
research [40]. We allocate extra time to case review at our
research center to clarify procedures and to help educate
graduate students serving as panel members on relevant
topics such as clinical trial management [13], diagnostic
reasoning, research ethics, and other critical aspects of
clinical research. With experienced personnel and a devel-
oped process, the efficiency of case presentation and eligi-
bility determination can be improved.
Exclusions during baseline visits conducted by a single
study coordinator do not involve clinical decision mak-
ing; rather, they are determined from objective measure-
ments (e.g., weight, pain level). However, it is possible
that enrollment error could occur due to incorrect data
entry. While individual research clinicians also make eli-
gibility determinations requiring clinical evaluation dur-
ing the baseline process, these decisions are focused on
facets of the participant’s health history that are similarly
objective (e.g., surgical status in past year). Thoughprocedures are designed to mitigate selection bias, sub-
jective decisions are still made by personnel subject to
unintentional bias and some decisions are made by a
single individual when consensus is not reached.
Conclusions
Case review is based on the concept of providing a for-
mally structured decision-making process that includes
at least one person from each of four roles: the con-
senting coordinator, examining clinician, project man-
ager, and an investigator. It also includes designated
steps to facilitate thorough case presentations, incorp-
orate user-friendly and secure access to operational def-
initions for eligibility across multiple trials conducted
simultaneously, moderate structured member discussions,
and provide a formalized decision-making process to ren-
der eligibility determinations that reflect the scientific ob-
jectives of a clinical trial.
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